Cambridge Cognition secures new £2.2 million contract

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has been selected as the cognitive assessment partner for a large at-home study.  The contract is valued at £2.2 million with revenue expected to be recognised by the Company over three years beginning in H2 2021.  This is the second, large, at-home cognitive testing contract the Company has secured in two months.  The previous one was announced on 8 April 2021 with a value of £0.5 million.

In delivering the contract, the Company will deploy web-based cognitive assessments (CANTABTM) monthly.  Cognition can fluctuate over the course of a day as well as over longer periods, therefore participants will be asked to periodically undertake short digital cognitive assessments up to three times a day.

Cambridge Cognition is uniquely positioned to secure this contract as its proprietary CANTAB™ cognitive assessments produce comparable performance whether delivered under supervision in clinics or unsupervised at home1,.  The Company also offers rapid assessments that have been validated for high-frequency testing on smartphones2

Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:

“As widely predicted, the COVID-19 pandemic has accelerated interest in virtual clinical trial assessments and Cambridge Cognition is well positioned to benefit from the consequent substantial growth opportunities.  We are pleased to have secured another large contract for a virtual clinical trial where we will be working with a leading pharmaceutical company in the sector.  The Company has established a robust science foundation and an excellent customer service record and this combination continues be rewarded by securing contracts for the growing field of virtual clinical trials.”

References

1.        Backx R, Skirrow C, Dente P, Barnett JH, Cormack FK. Comparing Web-Based and Lab-Based Cognitive Assessment Using CANTAB™. J Med Internet Res 2020;22(8):e16792. doi: 10.2196/16792

2.        Allen L, Baker E, Thorp E et. Validation and Comparison of a Digital Digit Symbol Substitution (DSST) Task Performed on Smart Phones With a Traditional Paper-Pencil Version. Biological Psychiatry 2020; 88(9). DOI: https://doi.org/10.1016/j.biopsych.2021.02.342

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition forms new Scientific Advisory Board

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, is pleased to announce the formation of a Scientific Advisory Board. This expert board will provide scientific guidance and valuable market insights, primarily focusing

Cambridge Cognition Holdings

Cambridge Cognition Holdings Changes its Auditor to Crowe UK LL

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Board has approved the appointment of Crowe UK LLP as the Group’s new external auditor following a competitive

Cambridge Cognition Holdings

Cambridge Cognition strengthens balance sheet with £3 million loan

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Company has obtained a £3.0 million loan from Claret European Specialty Lending Company III, S.à r.l.  Claret specialises in

Cambridge Cognition Holdings

Cambridge Cognition Holdings Revision to Explanatory Note

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the explanatory note to Resolution 7 in the Notice of the Annual General Meeting (“AGM”) to be held on 28 June 2023

Cambridge Cognition Holdings

Cambridge Cognition publishes Annual Report and Accounts

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2022 and the Notice of the Annual General

Cambridge Cognition Holdings

Cambridge Cognition growth strategy clearly paying off (VIDEO)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss prelim results for the year ended 31 December 2022. In this interview Matthew talks us through the result highlights, explains how the the acquisitions